(1S,2R)-rel-2-[(benzyloxy)carbonyl]cyclopropane-1-carboxylic acid, 95, 1g

(E)-4,4,5,5-Tetramethyl-2-(3-(trifluoromethyl)styryl)-1,3,2-dioxaborolane, 95+%, 100mg

2',3,4-Trifluoro-4''-propyl-1,1':4',1''-terphenyl>98.0%(GC)5g

dimethyl malonate, min 99%, for synthesis, 1 l, glass packaging

Dimethyl thiazolidine-2,4-dicarboxylate, 95+%, 5g

Ethyl 3-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)propanoate, 95.0%, 250mg

tert-butyl [3,3'-biazetidine]-1-carboxylate hydrochloride, 95.0%, 5g

2-Butyl-1-n-octanol>98.0%(GC)500mL

3,6-Dibromocarbazole>98.0%(GC)5g

N-(2-phenylethyl)cyclohexanamine hydrochloride, 95.0%, 1g

7-chloro-1H-[1,2,3]triazolo[4,5-d]pyrimidine, 98%, 250mg

Ethyl 5-amino-1,2,4-oxadiazole-3-carboxylate, 95.0%, 250mg

(2R,3S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-hydroxybutanoic acid hydrate, 95.0%, 1g